AstraZeneca and the brand-name drug industry’s leading trade group have filed federal lawsuits challenging newly enacted 340B contract pharmacy access [...] …
Category: Judicial
Following a string of losses in federal courts, some drugmakers are now turning to state-level courts in an effort to [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
A federal judge’s decision to uphold the government’s authority to pre-approve drugmaker 340B rebate models has drawn praise from providers, [...] …
A federal district judge last Friday allowed a key hospital trade group to intervene in Johnson & Johnson’s (J&J) lawsuit [...] …
Breaking News
Federal Judge Upholds HHS’ Right to Pre-Approve 340B Rebates, Tosses Four of Five Drugmaker Lawsuits
A federal district judge has upheld the federal government’s authority to require agency approval of drugmaker 340B rebate models, dealing [...] …
A key hospital group recently urged Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. to reject drugmaker 340B [...] …
Multiple hospital advocacy groups have filed an amicus brief urging a federal district judge to uphold Nebraska’s recently enacted 340B [...] …
Pharmaceutical giant AbbVie recently filed a federal lawsuit challenging Tennessee’s new 340B contract pharmacy access law—while also announcing plans to [...] …
Four major drugmakers and an industry vendor are urging a federal judge not to delay ruling on their 340B rebate [...] …